ClinicalTrials.Veeva

Menu

SVF Therapy for Human Knee Osteoarthritis

Z

Zhongnan Hospital

Status

Completed

Conditions

Knee Osteoarthritis

Treatments

Procedure: SVF treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT05019378
Zhongnanzxx

Details and patient eligibility

About

The purpose of the study is to asses the safety and efficacy of SVF for treatment of knee osteoarthritis, and establish a novel method to provide 3D MRI imaging for human knee cartilage to qualitatively and quantitatively evaluate cartilage regeneration.

Full description

Study participants voluntarily provided written informed consent to participate in the study. The two knees of each patient were randomly assigned to autologous SVF treatment group or non-treatment control group. The patients were evaluated every 4 weeks for safety and efficacy of autologous SVF therapy for 24 weeks.

Enrollment

6 patients

Sex

All

Ages

50 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Knee Osteoarthritis
  • Articular cartilage defect grades I/II of both knee

Exclusion criteria

  • autoimmune or inflammatory arthritis
  • serious medical disorders

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

6 participants in 2 patient groups

autologous SVF treatment
Experimental group
Description:
Three milliliter of cell suspension injection containing 1.0E8 SVF cells into the knee joint
Treatment:
Procedure: SVF treatment
Placebo group
No Intervention group
Description:
No treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems